Biosimilar erythropoietin alfa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biosimilar erythropoietin alfa, covering 2025-01-08 to 2025-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome